Y-BOX BINDING PROTEIN-1 ACTIVATION MAY MODIFY THE RESPONSES TO ENDOCRINE AND HER2-TARGETED THERAPEUTICS IN BREAST CANCER

被引：0
|
作者：
Kuwano, Michihiko [1 ]
Shibata, Tomohiro [2 ]
Kawahara, Akihiko [3 ]
Hattori, Satoshi [4 ]
Takahashi, Ryuji [5 ]
Watari, Kosuke [2 ]
Murakami, Yuichi [2 ]
Izumi, Hiroto [6 ]
Kage, Masayoshi [3 ]
Ono, Mayumi [2 ]
机构：
[1] Kyushu Univ, Lab Mol Canc Biol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan
[2] Kyushu Univ, Dept Pharmaceut Oncol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan
[3] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan
[4] Kurume Univ, Ctr Biostat, Kurume, Fukuoka, Japan
[5] Kyushu Med Ctr, Dept Breast Care Ctr, Fukuoka, Japan
[6] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu435.89
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O2-15-2
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Y-box binding protein-1/epidermal growth factor receptor pathway defines basal-like breast cancer and provides opportunities for targeted therapies.
    Habibi, G.
    Stratford, A.
    Law, J.
    Lee, C.
    Shadeo, A.
    Buys, T.
    Cheang, M.
    Lam, W.
    Gilks, C. B.
    Nielsen, T.
    Dunn, S. E.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S12 - S12
  • [22] Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy
    Zhang, Y.
    Reng, S. R.
    Wang, L.
    Lu, L.
    Zhao, Z. H.
    Zhang, Z. K.
    Feng, X. D.
    Ding, X. D.
    Wang, J.
    Feng, G.
    Dai, T. Z.
    Pu, J.
    Du, X. B.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1992 - 1997
  • [23] Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy
    Y. Zhang
    S. R. Reng
    L. Wang
    L. Lu
    Z. H. Zhao
    Z. K. Zhang
    X. D. Feng
    X. D. Ding
    J. Wang
    G. Feng
    T. Z. Dai
    J. Pu
    X. B. Du
    Medical Oncology, 2012, 29 : 1992 - 1997
  • [24] The antiestrogens 4-hydroxytamoxifen and fulvestrant are inhibitors of oncogenic factor Y-box binding protein-1 expression in breast cancer cells
    Stope, M. B.
    Popp, S. L.
    Joffroy, C.
    Mustea, A.
    Buck, M. B.
    Knabbe, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (05) : 764 - 768
  • [25] Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors
    Lettau, Konstanze
    Khozooei, Shayan
    Kosnopfel, Corinna
    Zips, Daniel
    Schittek, Birgit
    Toulany, Mahmoud
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 1072 - 1087
  • [26] Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma
    Fujiwara-Okada, Y.
    Matsumoto, Y.
    Fukushi, J.
    Setsu, N.
    Matsuura, S.
    Kamura, S.
    Fujiwara, T.
    Iida, K.
    Hatano, M.
    Nabeshima, A.
    Yamada, H.
    Ono, M.
    Oda, Y.
    Iwamoto, Y.
    BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 836 - 847
  • [27] Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability
    Law, Jennifer H.
    Li, Yvonne
    To, Karen
    Wang, Michelle
    Astanehe, Arezoo
    Lambie, Karen
    Dhillon, Jaspreet
    Jones, Steven J. M.
    Gleave, Martin E.
    Eaves, Connie J.
    Dunn, Sandra E.
    PLOS ONE, 2010, 5 (09): : 1 - 11
  • [28] Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma
    Y Fujiwara-Okada
    Y Matsumoto
    J Fukushi
    N Setsu
    S Matsuura
    S Kamura
    T Fujiwara
    K Iida
    M Hatano
    A Nabeshima
    H Yamada
    M Ono
    Y Oda
    Y Iwamoto
    British Journal of Cancer, 2013, 108 : 836 - 847
  • [29] Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer
    Panupinthu, N.
    Yu, S.
    Zhang, D.
    Zhang, F.
    Gagea, M.
    Lu, Y.
    Grandis, J. R.
    Dunn, S. E.
    Lee, H. Y.
    Mills, G. B.
    ONCOGENE, 2014, 33 (22) : 2846 - 2856
  • [30] Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer
    N Panupinthu
    S Yu
    D Zhang
    F Zhang
    M Gagea
    Y Lu
    J R Grandis
    S E Dunn
    H Y Lee
    G B Mills
    Oncogene, 2014, 33 : 2846 - 2856
12345